Provexis (CHIX:PXSL) Common Stock: £2.35 Mil (As of Sep. 2025)


What is Provexis Common Stock?

Provexis CHIX:PXSL Common Stock is £2.35 Mil as of Sep. 2025. The stock has 1 warning sign investors should review.

Provexis's quarterly common stock increased from Sep. 2024 (£2.26 Mil) to Mar. 2025 (£2.35 Mil) but then stayed the same from Mar. 2025 (£2.35 Mil) to Sep. 2025 (£2.35 Mil).

Provexis's annual common stock stayed the same from Mar. 2023 (£2.22 Mil) to Mar. 2024 (£2.22 Mil) but then increased from Mar. 2024 (£2.22 Mil) to Mar. 2025 (£2.35 Mil).

Provexis Common Stock Historical Data

* Premium members only.

The historical data trend for Provexis's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Provexis Common Stock Chart

Provexis Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.21 2.21 2.22 2.22 2.35

Provexis Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 2.22 2.26 2.35 2.35

Provexis Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of £2.35 Mil mean?
Provexis (CHIX:PXSL) has a Common Stock of £2.35 Mil as of Sep. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Provexis and its competitors.
Is Provexis' Common Stock too high?
Provexis' current Common Stock is £2.35 Mil.
How does Provexis' Common Stock compare to ZTS and UTHR?
Provexis' Common Stock of £2.35 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Provexis and its competitors. Provexis's current Common Stock is £2.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Provexis stock overvalued right now?
Provexis (CHIX:PXSL) has a current Common Stock of £2.35 Mil. The current Common Stock is £2.35 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Provexis (CHIX:PXSL), the current Common Stock is £2.35 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Provexis Business Description

Other Exchanges PXS:UKNZCA:Germany
Address 2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ
Provexis PLC is engaged in developing, licensing and selling the proprietary, scientific Fruitflow heart-health functional food ingredient for the global functional food sector. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.